Edmonson, J H <br/><br/>
Comparison of conventional dose and double dose carboplatin in patients receiving cyclophosphamide plus carboplatin for advanced ovarian carcinoma: a North Central Cancer Treatment Group Study.  [electronic resource] 

 -  Cancer investigation  2001 
 - 597-602 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0735-7907 
<br/><br/><label>Standard No.: </label>10.1081/cnv-100104287  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Black People<br/>Carboplatin--administration & dosage<br/>Combined Modality Therapy<br/>Cyclophosphamide--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Granulocyte-Macrophage Colony-Stimulating Factor--administration & dosage<br/>Humans<br/>Middle Aged<br/>Midwestern United States<br/>Ovarian Neoplasms--drug therapy<br/>Recombinant Proteins--administration & dosage<br/>Survival Rate<br/>White People<br/>Black or African American